Themes in Fibrosis and Gastrointestinal Inflammation.
Claudio Fiocchi and P. Kay Lund.
Am J Physiol Gastrointest Liver Physiol 300: G677-G683.
First published March 17, 2011; doi: 10.1152/ajpgi.00104.2011.
Intestinal myofibroblasts: targets for stem cell
therapy.
R. C. Mifflin, I. V. Pinchuk, J. I. Saada, and D. W. Powell.
Am J Physiol Gastrointest Liver Physiol 300: G684-G696.
First published January 20, 2011; doi:10.1152/ajpgi.00474.2010.
Obesity, diabetes mellitus, and liver fibrosis.
Dian J. Chiang, Michele
T. Pritchard, and Laura
E. Nagy.
Am J Physiol Gastrointest Liver Physiol 300:
G697-G702. First published February 24, 2011;
doi:10.1152/ajpgi.00426.2010.
Mesenchymal cell proliferation and programmed cell death: key
players in fibrogenesis and new targets for therapeutic
intervention.
Jeroni Luna, Maria
Carme Masamunt, Ian Craig Lawrance, and Miquel Sans.
Am J Physiol Gastrointest Liver Physiol 300: G703-G708.
First published January 13, 2011; doi:10.1152/ajpgi.00504.2010.
Therapeutic targets in liver fibrosis.
Jonathan A. Fallowfield.
Am J Physiol Gastrointest Liver Physiol 300: G709-G715.
First published January 13, 2011; doi:10.1152/ajpgi.00451.2010.
Immune and nonimmune components orchestrate the pathogenesis of
inflammatory bowel disease.
Silvio Danese.
Am J Physiol Gastrointest Liver Physiol 300: G716-G722.
First published January 13, 2011; doi:10.1152/ajpgi.00472.2010.
Fibrosis is regulated by Th2 and Th17 responses and by dynamic
interactions between fibroblasts and macrophages.
Luke Barron and Thomas
A. Wynn.
Am J Physiol Gastrointest Liver Physiol 300: G723-G728;
published ahead of print February 3,
2011; doi:10.1152/ajpgi.00414.2010.
Animal models for the study of liver fibrosis: new insights from
knockout mouse models
Hiromitsu Hayashi and Takao
Sakai
Am J Physiol Gastrointest Liver Physiol 300:
G729-G738. First published February 24, 2011;
doi:10.1152/ajpgi.00013.2011.